Search Results 1311-1320 of 2910 for site:slotspk17.com

  1. A Study Of Ripretinib Vs Sunitinib In Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib - Mayo Clinic

    The purpose of this study is to compare the objective response rate (ORR) by IRR of ripretinib vs sunitinib using modified Response Evaluation Criteria in Solid ...

  2. Pulmonary Medicine - Clinical trials

    Learn about the expertise and wide range of services at Mayo Clinic for people with complex or serious conditions that affect the lungs and breathing.

  3. Study To Evaluate The Safety, Tolerability And Efficacy Of CT1812 In Subjects With Mild To Moderate Dementia With Lewy Bodies - Mayo Clinic

    The purpose of this study is to assess the safety and tolerability of CT1812 as a treatment for mild-to-moderate Dementia with Lewy Bodies. Participation ...

  4. Clinical trials - Oncology (Medical)

    There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

  5. Evaluation Of The Safety And Efficacy Of Eneboparatide (AZP-3601) In Patients With Chronic Hypoparathyroidism - Mayo Clinic

    The purpose of this study is to investigate the safety and effectiveness of eneboparatide (AZP-3601) in patients with chronic hypoparathyroidism (cHP).

  6. Oncology (Medical) - Clinical trials - Mayo Clinic

    This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL.

  7. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  8. Phase 2 Study With TTI-622 And TTI-621 In Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    About this study. The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab ...

  9. (HARBOR) Study To Evaluate Efficacy And Safety Of BLU-263 Versus Placebo In Patients With Indolent Systemic Mastocytosis - Mayo Clinic

    The purpose of this study to determine recommended dose (RD) of BLU-263 for patients with Indolent Systemic Mastocytosis. Participation eligibility. Participant ...

  10. Oncology (Medical) - Clinical trials

    Rochester, Minn. This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with ...